[go: up one dir, main page]

NO20016283L - Tidsbestemte doseringsformer med dobbeltfrigivelse som omfatter et kortvirkende hypnotikum eller et salt derav - Google Patents

Tidsbestemte doseringsformer med dobbeltfrigivelse som omfatter et kortvirkende hypnotikum eller et salt derav

Info

Publication number
NO20016283L
NO20016283L NO20016283A NO20016283A NO20016283L NO 20016283 L NO20016283 L NO 20016283L NO 20016283 A NO20016283 A NO 20016283A NO 20016283 A NO20016283 A NO 20016283A NO 20016283 L NO20016283 L NO 20016283L
Authority
NO
Norway
Prior art keywords
salt
short
dosage forms
release dosage
acting hypnotic
Prior art date
Application number
NO20016283A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016283D0 (no
Inventor
Gerard Alaux
Frederic Andre
Jean Ducassou
Gareth Lewis
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8242028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20016283(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20016283D0 publication Critical patent/NO20016283D0/no
Publication of NO20016283L publication Critical patent/NO20016283L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20016283A 1999-06-28 2001-12-20 Tidsbestemte doseringsformer med dobbeltfrigivelse som omfatter et kortvirkende hypnotikum eller et salt derav NO20016283L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401605A EP1064937A1 (fr) 1999-06-28 1999-06-28 Formes pharmaceutiques à liberation controllée comprenant un hypnotique à courte duree ou une des ses sels
PCT/EP2000/006792 WO2001000181A2 (fr) 1999-06-28 2000-06-27 Formes de dosage a double liberation dans le temps comprenant un hypnotique, ou un de ses sels, a action breve

Publications (2)

Publication Number Publication Date
NO20016283D0 NO20016283D0 (no) 2001-12-20
NO20016283L true NO20016283L (no) 2002-02-27

Family

ID=8242028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016283A NO20016283L (no) 1999-06-28 2001-12-20 Tidsbestemte doseringsformer med dobbeltfrigivelse som omfatter et kortvirkende hypnotikum eller et salt derav

Country Status (28)

Country Link
EP (2) EP1064937A1 (fr)
JP (1) JP2003503340A (fr)
KR (1) KR20020015064A (fr)
CN (1) CN100415216C (fr)
AR (1) AR024491A1 (fr)
AT (1) ATE269062T1 (fr)
AU (1) AU782162B2 (fr)
BR (1) BR0011994A (fr)
CA (1) CA2370556C (fr)
CO (1) CO5190680A1 (fr)
CZ (1) CZ20014640A3 (fr)
DE (1) DE60011617T2 (fr)
DK (1) DK1194132T3 (fr)
ES (1) ES2222223T3 (fr)
HK (1) HK1043057B (fr)
HU (1) HU227810B1 (fr)
IL (1) IL146928A0 (fr)
MX (1) MXPA01013212A (fr)
NO (1) NO20016283L (fr)
NZ (1) NZ515997A (fr)
PL (1) PL201777B1 (fr)
PT (1) PT1194132E (fr)
SI (1) SI1194132T1 (fr)
SK (1) SK285347B6 (fr)
TR (1) TR200103594T2 (fr)
TW (1) TWI285118B (fr)
WO (1) WO2001000181A2 (fr)
ZA (1) ZA200110005B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064938A1 (fr) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Formes pharmaceutiques à libération contrôlée avec au moins une impulsion temporelle
ATE241968T1 (de) * 1999-08-26 2003-06-15 Neurocrine Biosciences Inc Sedativ hypnotische zusammensetzungen mit gesteuerter freisetzung und diesbezügliche verfahren
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US7811557B1 (en) * 2000-10-27 2010-10-12 Viacell, Inc. Methods for improving central nervous system functioning
CA2447008A1 (fr) * 2001-04-05 2002-10-24 Collagenex Pharmaceuticals, Inc. Delivrance controlee de composes de tetracycline et de derives de tetracycline
DE60223254T2 (de) 2001-07-06 2008-08-14 Penwest Pharmaceuticals Co. Verzögert freisetzende formulierungen von oxymorphon
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
JP2005515966A (ja) 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ， インコーポレイティド 鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
CN1606434A (zh) * 2001-12-19 2005-04-13 株式会社三和化学研究所 控制释放成型品
US20030165566A1 (en) * 2002-01-10 2003-09-04 O'toole Edel Sedative non-benzodiazepine formulations
EP1941878A1 (fr) * 2002-01-10 2008-07-09 Biovail Laboratories International Srl Formules sédatives sans benzodiazépine
WO2003059349A1 (fr) * 2002-01-10 2003-07-24 Biovail Laboratories Inc. Formulations de non-benzodiazepine sedative
JP2006506461A (ja) * 2002-10-25 2006-02-23 コルジウム ファーマシューティカル， インコーポレイテッド ミルナシプランのパルス型放出組成物
JP4681843B2 (ja) * 2004-09-30 2011-05-11 日本臓器製薬株式会社 固形医薬製剤
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
FR2887455B1 (fr) * 2005-06-28 2007-08-10 Sanofi Aventis Sa Formulation a liberation prolongee de principes actifs de medicaments
DE602006008339D1 (en) * 2005-11-18 2009-09-17 Synhton B V Zolpidemtabletten
AR056633A1 (es) * 2005-12-07 2007-10-17 Gador Sa Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones
US8309104B2 (en) * 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
KR20070091960A (ko) * 2006-03-08 2007-09-12 주식회사종근당 졸피뎀 또는 그의 염을 포함하는 안전한 제어방출형 제제조성물
AU2013202441B2 (en) * 2006-04-26 2016-02-25 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
PL2010158T3 (pl) * 2006-04-26 2016-09-30 Formulacje o kontrolowanym uwalnianiu zawierające niepowlekaną odrębną jednostkę(-i) i macierz o przedłużonym uwalnianiu
JP5275560B2 (ja) * 2006-10-24 2013-08-28 小林化工株式会社 酒石酸ゾルピデム含有素錠の製造方法
EP1938805A1 (fr) * 2006-12-22 2008-07-02 LEK Pharmaceuticals D.D. Comprimés monolithiques de zolpidem à libération prolongée
EP1970056A1 (fr) * 2007-03-15 2008-09-17 Polichem S.A. Formules de dosages à libération retardée/pulsatile spécifique au temps
WO2009021127A2 (fr) * 2007-08-07 2009-02-12 Neurogen Corporation Compositions à libération lente
EP3115043B1 (fr) 2008-04-18 2020-11-25 Intec Pharma Ltd. Administration de médicament à rétention gastrique de lévodopa/carbidopa
US20100068283A1 (en) 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex VIVO modifiable particle or polymeric material medicament carrier
WO2010064139A2 (fr) 2008-12-04 2010-06-10 Intec Pharma Ltd. Système de d'administration de médicament à rétention gastrique pour le zaleplon
RU2384336C1 (ru) * 2009-04-22 2010-03-20 Маргарита Алексеевна Морозова Фармацевтический состав для коррекции психосоматических проявлений
WO2011005250A1 (fr) * 2009-07-07 2011-01-13 Sepracor Inc. Formulations de 6-(5-chloro-2-pyridyl)-5-[(4-méthyl-1-pipérazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
FR2949062B1 (fr) * 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
TWI505841B (zh) * 2011-09-29 2015-11-01 Taiwan Biotech Co Ltd 治療睡眠障礙之控釋調配物
PT3102189T (pt) * 2014-02-06 2019-12-11 Bo Chen Lan Composição e método para melhorar o sono
RU2659200C1 (ru) * 2017-07-24 2018-06-28 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтический состав, содержащий алимемазина тартрат

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
GB2185887B (en) * 1987-02-18 1989-12-06 Farmitalia Carlo Erba Ltd Temazepam composition
DE68916497T2 (de) * 1988-09-30 1994-11-17 Rhone Poulenc Rorer Ltd Pharmazeutisches Granulat.
FR2656303B1 (fr) * 1989-12-26 1994-06-10 Parke Davis Solution buvable d'un derive des benzodiazepines et son application pharmacologique.
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
BR9802915A (pt) * 1997-09-12 2000-01-11 Oscar Gold Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um)
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
EP1005863A1 (fr) * 1998-12-04 2000-06-07 Synthelabo Formes galeniques a liberation controlee contenant un hypnotique a activite courte ou un sel de ce compose

Also Published As

Publication number Publication date
WO2001000181A2 (fr) 2001-01-04
CZ20014640A3 (cs) 2002-03-13
SK19112001A3 (sk) 2002-05-09
MXPA01013212A (es) 2002-06-21
ZA200110005B (en) 2003-02-26
SI1194132T1 (en) 2004-10-31
EP1064937A1 (fr) 2001-01-03
EP1194132A2 (fr) 2002-04-10
PL201777B1 (pl) 2009-05-29
HK1043057B (en) 2005-02-25
AU6694400A (en) 2001-01-31
PL357348A1 (en) 2004-07-26
HUP0201907A3 (en) 2004-05-28
CN1358087A (zh) 2002-07-10
KR20020015064A (ko) 2002-02-27
WO2001000181A3 (fr) 2001-03-01
PT1194132E (pt) 2004-10-29
DE60011617T2 (de) 2005-06-09
HUP0201907A2 (hu) 2002-12-28
IL146928A0 (en) 2002-08-14
CN100415216C (zh) 2008-09-03
NO20016283D0 (no) 2001-12-20
DK1194132T3 (da) 2004-10-11
NZ515997A (en) 2004-03-26
CA2370556C (fr) 2009-09-01
DE60011617D1 (de) 2004-07-22
ATE269062T1 (de) 2004-07-15
HU227810B1 (en) 2012-03-28
BR0011994A (pt) 2002-03-05
CA2370556A1 (fr) 2001-01-04
TR200103594T2 (tr) 2002-06-21
JP2003503340A (ja) 2003-01-28
ES2222223T3 (es) 2005-02-01
AR024491A1 (es) 2002-10-02
TWI285118B (en) 2007-08-11
EP1194132B1 (fr) 2004-06-16
SK285347B6 (sk) 2006-11-03
CO5190680A1 (es) 2002-08-29
AU782162B2 (en) 2005-07-07
HK1043057A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
NO20016283D0 (no) Tidsbestemte doseringsformer med dobbeltfrigivelse som omfatter et kortvirkende hypnotikum eller et salt derav
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
NO20032735L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
DK1207867T3 (da) Retarderede, orale farmaceutiske indgivelsesformer med tramadol
ITTO20010008A0 (it) Formulazione farmaceutica
DK1207868T3 (da) Farmaceutiske tramadolsalte
NO20032909L (no) Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
DK1135125T3 (da) Doseringsformer med reguleret frigivelse omfattende zolpidem eller et salt deraf
NO20002486L (no) Sykliske aminderivater og deres anvendelse som legemidler
NO2013004I1 (no) axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
ATE258928T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
ID24654A (id) Formulasi farmasi omeprazola
ATE259796T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
EE200100611A (et) NOS inhibiitorite uued farmatseutilised kombinatsioonid
DK1216250T3 (da) Thienoisoxazolyl- og thienylpyrazolyl-phenoxy- substituerede propylderivater som D4-antagonister
ID30032A (id) Formulasi farmasi
DK1227817T3 (da) Ciclesonid-holdigt vandigt farmaceutisk præparat
DK199900435U3 (da) Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20004816D0 (no) Ny farmasøytisk formulering
NO20032957D0 (no) Farmasöytisk emulsjonspreparat
EE200300045A (et) Kristalne ravimaine
NO20021249D0 (no) Tienoisoksazolfenoksyusubstituerte etyl- og propylderivater som D4antagonister